Avidity Partners Management’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-258,000
| Closed | -$6.97M | – | 68 |
|
2025
Q1 | $6.97M | Sell |
258,000
-483,900
| -65% | -$13.1M | 1.33% | 31 |
|
2024
Q4 | $39.7M | Buy |
741,900
+179,900
| +32% | +$9.63M | 3.9% | 3 |
|
2024
Q3 | $25.5M | Sell |
562,000
-278,219
| -33% | -$12.6M | 1.3% | 32 |
|
2024
Q2 | $35.2M | Buy |
840,219
+455,974
| +119% | +$19.1M | 1.5% | 25 |
|
2024
Q1 | $14.5M | Buy |
+384,245
| New | +$14.5M | 0.47% | 56 |
|